NICE Appraisals

Health written question – answered on 20th March 2006.

Alert me about debates like this

Photo of John Hemming John Hemming Member, Regulatory Reform Committee 20th March 2006

To ask the Secretary of State for Health who authorised the signing of the contract between the National Institute of Clinical Excellence (NICE) and Southampton Technology Assessment Centre (SHTAC) that provides that the cost-effectiveness model prepared by SHTAC for NICE for consideration in the technology appraisal of donepezil, rivastigmine, galantamine and memantine for the treatment of Alzheimer's disease cannot be disclosed under the Freedom of Information Act 2000; and if she will make a statement.

Photo of Jane Kennedy Jane Kennedy Minister of State (Quality and Patient Safety), Department of Health 20th March 2006

The contract, with the University of Southampton, for technology assessment review reports was authorised by the Department's director of research and development (R&D) and signed by an official on behalf of the Secretary of State for Health. It is a standard Departmental R&D contract, which invests intellectual property with the research contractor. Details of the relevant intellectual property policy is available on the Department's website at: www.dh.gov.uk/PolicyAndGuidance/ResearchAndDevelopment.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.

Annotations

No annotations

Sign in or join to post a public annotation.